Pharmacyclics (PCYC) Shares Hit New 52-Week High as Investors Still Bullish on Ibrutinib, Pipeline

Go back to Pharmacyclics (PCYC) Shares Hit New 52-Week High as Investors Still Bullish on Ibrutinib, Pipeline